Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Genentech Patient Foundation Responds to NHF-HFA Letter
HEMLIBRA® Granted Priority Review by FDA
Industry
Bayer Responds to NHF-HFA Joint Statement
FDA Approves New Vial Size for Idelvion®
Industry
uniQure Announces First Hemophilia B Patient Treated in Phase III Gene Therapy Trial
uniQure Reports Successful Delivery of FIX Gene Therapy Despite Antibodies…
Industry
Spark Sees Continued Progress in Hemophilia B Gene Therapy
Spark Sees Continued Progress in Hemophilia B Gene Therapy
Industry
Genentech Announces Positive HEMLIBRA Trial Results
Genentech Announces Positive HEMLIBRA Trial Results
Industry
Genentech Patient Foundation Responds to NHF-HFA Letter
HEMLIBRA® Receives Breakthrough Designation from FDA
Industry
ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
ICER Review of Emicizumab for People with Hemophilia A and Inhibitors
Industry
Genentech Provides Updates on Hemlibra Product Particles
Grifols Announces 2017 Factor Product Donations to WFH Humanitarian…
Industry
Genentech Announces Positive HEMLIBRA Trial Results
Statement from Genentech Regarding Hemlibra
Industry
New Inhibitor Screening Kit Unveiled at THSNA
New Inhibitor Screening Kit Unveiled at THSNA
Industry
NHF-McMasters Guidelines on ECRI
Aptevo Announces Patient-Reported Study Results Related to IXINITY® Use
Industry
Hemlibra Safety Update
Novo Nordisk Announces BLA Submission for Extended Half-Life FVIII Therapy…
Industry
Genentech Announces Positive HEMLIBRA Trial Results
REBINYN® Now Available for Hemophilia B Patients
Industry
New Inhibitor Screening Kit Unveiled at THSNA
Catalyst Begins Phase 2/3 Trial of Investigational Subcutaneous Therapy
Industry
Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial
BioMarin Reports Positive Gene Therapy Trial Data at ASH